SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-19-000004
Filing Date
2019-02-04
Accepted
2019-02-04 16:09:02
Documents
4
Period of Report
2019-01-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 37307
2 EXHIBIT 3.1 finalpirs-certificateofdes.htm EX-3.1 82534
3 EXHIBIT 10.1 bvf-pirs3a9exchangeagreeme.htm EX-10.1 136697
4 bvfpirs3a9exchangeagr_image1.gif GRAPHIC 5560
  Complete submission text file 0001583648-19-000004.txt   265807
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 19563767
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9